Jürgen Borlak

16PUBLICATIONS
2CO-AUTHORS
Food properties (incl. characteristics and health benefits)Medical infection agents (incl. prions)Predictive and prognostic markersMolecular targetsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 01, 2026
Clinical plausibility of eggshell membrane proteins for osteoarthritis: a study of solubility, digestibility, and immune response.

|Jun 26, 2025
Diclofenac Immune-Mediated Hepatitis: Identification of Innate and Adaptive Immune Responses at Clinically Relevant Doses.

Jürgen Borlak, Reinhard Spanel

|Mar 28, 2025
ATT-Myc Transgenic Mouse Model and Gene Expression Identify Genotoxic and Non-Genotoxic Chemicals That Accelerating Liver Tumor Growth in Short-Term Toxicity.

Mahmoud Elalfy, Jürgen Borlak, Ahmed Jaafar Aljazzar

|Feb 25, 2025
Comprehensive transcriptome, miRNA and kinome profiling identifies new treatment options for personalized lung cancer therapy.

Shen Zhong, Yvonne Börgeling, Patrick Zardo

|Feb 17, 2025
A comparative genomic study across 396 liver biopsies provides deep insight into FGF21 mode of action as a therapeutic agent in metabolic dysfunction-associated steatotic liver disease.

Shifang Tang, Jürgen Borlak

|Sep 16, 2024
The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes.

Jürgen Borlak, Yari Ciribilli, Alessandra Bisio

Pageof 3

Frequent Collaborators

1 joint publications

Shifang Tang

1 joint publications

Ahmed Jaafar Aljazzar